["{\"step_by_step_thinking\": \"The patient has a low leukocyte count with 5% segmented neutrophils and 95% lymphocytes. The studies suggest that surgical stress can stimulate the release of polymorphonuclear leukocyte elastase from segmented neutrophils, but this is not relevant to the current situation. Leukocytosis is the least common response to acute rejection, and a sudden decrease in leukocyte count can be an early sign of rejection. However, this patient's condition does not match any of these scenarios.\n\nThe case report on lung cancer with eosinophilia suggests that the tumor may produce an eosinophil-proliferating factor, which is not relevant to the current situation.\n\nA review of the available options shows that filgrastim stimulates the production and differentiation of neutrophils in the bone marrow. Since the patient has a low leukocyte count with 5% segmented neutrophils, filgrastim may be beneficial in increasing this patient's leukocyte count.\n\nIn contrast, darbepoetin is an erythropoiesis-stimulating agent that increases red blood cell production. Dexamethasone can cause leukopenia and thrombocytopenia. Interferon alfa can cause neutropenia and thrombocytopenia.\n\nTherefore, the most appropriate pharmacotherapy to increase this patient's leukocyte count is filgrastim.\", \"answer_choice\": C}"]